A B S T R A O . The potential endotoxin modifying effects of subinhibitory doses of polymyxin B were evaluated in an animal model of overwhelming septicemia. Five to six day old Sprague-Dawley rats were infected intraperitoneally with lo6-lo7 cfu of Haemophilus influenzae type b. At 1 2 h after infection, a t which time mortality was 1870, subinhibitory doses of polymyxin b (0.0125 mg/kg x 3 q 3 h) either alone or in combination with 500 mg/kg ampicillin significantly increased survival a t 1 7 and 20 h (p = 0.009, 0.01 and p = 0.003, 0.01) compared to animals treated with 0.5 mg/kg of ampicillin alone. Prolonged survival a t 36 h ( p = 0.009) was seen in animals receiving both ampicillin and low dose polymyxin compared to either ampicillin dose alone. Ampicillin significantly reduced the number of bacteria in blood of survivors ( p < 0.023 a t 30 min) compared to untreated animals but increased the activity of free endotoxin a t 30 min compared to controls ( p = 0.006). I n vitro endotoxin release from H. influenzae type b increased 5-fold after addition of 100 pg/rnl of ampicilin, whereas a six-fold reduction in endotoxin activity was measured after the addition of 7 pg/ml of polymyxin B. Subinhibitory doses of polymyxin B modulate the ethal effects of overwhelming H. influenzae type b infection in infant rats and might be beneficial a s adjunct treatment in gram-negative septicemia. (Pediatr Res 20: 237-241,1986 philic polysaccharide, a core, and a hydrophobic lipid component, the lipid A. The polysaccharide determines the immunological specificity of the given LPS whereas lipid A, also endowed with antigenic properties, is responsible for the biologic activities of LPS (1). The role of endotoxin in the pathogenesis of shock associated with gram-negative bacteria in humans is not clear; however, the fact that antibodies directed against the core region of LPS significantly decrease mortality in humans with gram-negative infections supports the probability of some contribution of endotoxin to the physiologic effects seen in septic shock (2).
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Shenep et al. (3, 4) have demonstrated the release of endotoxin from Escherichia coli by antimicrobial agents in a rabbit model. Some children with Hib meningitis, who initially have normal peripheral perfusion, develop septic shock within 1 to 2 h after receiving their first dose of antibiotics. The LPS of Hib is similar in biological action to LPS from other gram-negative bacteria (5) . Further indirect evidence that LPS contributes to the virulence of Hib includes the observation that antibodies against the related E. coli J5 LPS core antigen protects six to 8-wk-old mice against death due to Hib infection (6) .
Polymyxin B is a cationic, cyclic polypeptide antibiotic that specifically binds to the lipid A-core region of LPS, disrupting the outer membrane. This action neutralizes endotoxin effects in vitro and in vivo (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . However, the neutralizing effect was only seen if polymyxin B was administered in advance or in conjunction with artificially purified endotoxin. This finding was thought to preclude the usefulness of polymyxin B as a neutralizing agent in clinical situations. The recent demonstration of endotoxin release by the action of commonly used antimicrobial agents in vivo suggests that the coadministration of polymyxin B with an endotoxin releasing antibiotic might be advantageous (3, 4) .
This study investigates the release of endotoxin from Hib by antibiotics in vitro and in vivo and the protective effect of low dose polymyxin B in an infant rat model of overwhelming Hib infection.
MATERIALS AND METHODS
In vitro release of endotoxin by antibiotics. HibE, kindly provided by Dr. T. J. Inzana, was employed in all experiments. Aliquots were frozen at -70" C in buffered glycerol-tryptic soy broth and were thawed and refrozen once. HibE was grown in brain heart infusion broth, supplemented with nicotinamide 238 WALTERSPI adenine dinucleotide and hemin (BHIS) (10 &/ml each, Sigma Chemical Co., St. Louis, MO). One milliliter of an overnight broth culture was added to 9 ml fresh medium in a 25-ml Erlenmeyer flask and incubated for 2 h at 35" C on a rotary shaker at 150 rpm. A baseline colony count was performed and antibiotics were added to achieve final concentrations approximating achievable peak serum concentrations in humans:
Ampicillin (Bristol Laboratories, Syracuse, NY) 100 &/ml, chloramphenicol (Parke Davis, Morris Plains, NJ) 25 @/ml, polymyxin B (Aerosporin, Burroughs Wellcome, Research Triangle Park, NC) 7 Fg/ml, and colistinmethanate sodium (Warner/Chilcott, Monis Plains, NJ) 5 pg/ml. Two samples containing no antibiotic served as controls. One control flask was held at 4" C to prevent further replication; one control and all samples were incubated at 35" C after the addition of the antibiotics. Colony counts were performed at 2, 6, and 22 h. Similarly, polymyxin B at 0.1, 0.0 1, and 0.00 1 pg/l and a combination of ampicillin 100 Fg/ml and polymyxin B at 0.1 pg/ml versus ampicillin alone were evaluated at 2 and 6 h after their addition to the cultures.
Cell free endotoxin activity was determined by removing 1 ml aliquots of bacterial suspension for colony quantitation after centrifugation at 12,000 x g for 10 min. The supernates were filtered through 0.22-p filters (Millipore Co., Bedford, MA) and sterility verified by subculture to chocolate agar. Serial 10-fold dilutions of the filtered supernates were prepared with pyrogen free water and assayed for their endotoxin activity.
Determination of endotoxin activity in vitro and in vivo. Endotoxin activity was quantified by comparison to activity of E. coli 0 1 1 1 :B4 standard (LPS) endotoxin in pyrogen-free water. Glassware and equipment were pyrogen free or rendered pyrogen free by baking at 160" C overnight. The chromogenic substrate S 2423 (AB Kabi Stockholm, Sweden) was used as an indicator for the limulus amoebocyte lysate reaction with endotoxin (QCL 1000, Whittaker, MA Bioproducts, Walkersville, MD) as described by Friberger et al. (17) . The reaction was stopped by addition of 50% acetic acid and the optical density was determined at 405 nm using a MR530 MicroElisa Reader (Dynatech Laboratories, Inc., Alexandria, VA). This standard curve is linear over endotoxin concentrations between 0.0 1-0.1 ng/ml (0.1 -1.0 endotoxin U/ml). Final endotoxin activity of the sample was calculated by multiplying the concentrations obtained from the standard curve by the dilution factor necessary to obtain an OD reading within the standard curve. We found that the addition of polymyxin B at 7 pg/ml to the chromogenic substrate does not interfere with this assay. The activity of LPS derived from HibE obtained by the phenol-water method (kindly supplied by Dr. T. J. Inzana) was 100 times less active on a weight basis than the standard endotoxin in this assay ( 18) .
To measure free endotoxin activity in whole blood, 0.0 1 ml of blood was diluted in 3 ml of pyrogen free normal saline and gently filtered through a 0.45y filter unit (Millex HA, Millipore CO.) to remove bacteria. Red blood cells were lysed by the filtration process but the dilution was suficient to avoid nonspecific light absorption from hemoglobin. The filtrate was immediately frozen at -20" C until assayed. Several healthy animals did not demonstrate any blood endotoxin activity using this method.
Experimental infection. Pathogen-free, outbred albino Sprague Dawley infant rats purchased with their mothers from Harlan Sprague Dawley, Inc., Houston, TX were used throughout the experiments. Litters contained eight to 14 animals and were mixed randomly before the experiments were initiated. Food and water were freely available and the animals were housed under standard conditions. All animals were weighed and infected when 5 to 6 days old.
One milliter of BHIS overnight broth culture of strain Eagan was added to 9 ml of fresh BHIS and incubated on a rotary shaker at 150 rpm for 2% h at 35" C. The culture was centrifuged at 12,000 x g for 10 minutes, washed once with phosphate buffered saline containing 0.1% gelatin (Difco Laboratories, Detroit, MI) and was resuspended in PBS containing 0.1 % gelatin to a concentration of 10' cfu/ml. The minimal inhibitory concentrations of ampicillin and polymyxin B for HibE were 0.1 and 0.003 &ml, respectively. Ampicillin and polymyxin B were not synergistic against HibE in vitro.
Animals were injected intraperitoneally with 0.1 ml of a 10-fold dilution (lo6 cfu) on the left side of the abdomen. To minimize leakage, needles were passed subcutaneously for a short distance prior to entering the peritoneal cavity.
In order to estimate a delay of antimicrobial treatment so that an otherwise adequate dose of ampicillin would not prevent death, 16 animals were infected ip with 9.6 x lo6 cfu of HibE. Treatment was delayed for 3, 6, 9, or 12 h after infection. When the delay was 12 h after infection, ampicillin did not decrease mortality. Survival and in vivo endotoxin release studies were initiated 12 h after HibE infection unless indicated otherwise.
Statistical analysis. Statistical analysis was performed with the two-tailed Fisher's exact test for survival at predetermined times and for the presence of bacteremia. Endotoxin activities and colony counts in the in vivo experiments were not Gaussian in distribution, therefore, results were analyzed with the Wilcoxon Mann Whitney rank sum test.
RESULTS

Effect of antibiotics on in vitro release of endotoxin by Hib in broth.
Endotoxin activities in brain heart infusion broth, NAD/ hemin supplement, and antibiotic solutions were 20, 10, and 50.02 ng/ml, respectively. The results of two separate experiments examining the in vitro release of endotoxin by HibE after exposure to antibiotics at peak serum levels attainable in humans are shown in Table 1 . Prior to the addition of antibiotics initial colony counts were 4.3 and 4.7 x 10' cfu/ml and filtered supernatants demonstrated endotoxin activity of 1000 ng/ml. Refrigeration at 4" C halted bacterial multiplication at 2 and 6 h and a 3 to 4 log loss of viability was seen at 22 h; the activity of cell free endotoxin did not increase during the first 6 h and tripled at 22 h. In comparison, colony counts in the incubated control sample increased 1 log by 2 h and there was a 20-fold increase in endotoxin activity observed at 22 h.
Addition of ampicillin or chloramphenicol reduced colony counts by 2 logs and increased the cell-free endotoxin activity at least 25-fold at 6 h compared to the values found for the refrigerated controls and 5-fold against incubated control samples. Polymyxin B was the most effective bactericidal antibiotic and decreased the level of cell free endotoxin activity to onesixth of the initial level. Addition of colistinmethanate was associated with a reduction in bacterial viability at 22 h similar to untreated controls but with a reduction in cell-free endotoxin activity.
The results of identical experiments after addition of low doses of polymyxin B at 0.1, 0.0 1, or 0.00 1 pg/ml, or a combination of 100 ,~g/ml ampicillin and 0.1 &ml polymyxin B versus ampicillin alone are shown in Table 2 . These low concentrations of polymyxin B alone or in combination with ampicillin exerted only minimal effects on colony forming units or endotoxin activities.
Determination of in vivo antimicrobial effects of ampicillin and low dose polymyxin B. Thirty-two infant rats were infected intraperitoneally with between 1.5 to 2.4 x lo6 cfu HibE. Twelve animals were treated with ampicillin alone at 0.5 mg/kg/dose ip and 20 with polymyxin B alone at 0.0125 mg/kg/dose ip. (This low dose of polymyxin B was selected on the basis of preliminary experiments which demonstrated that this dose was not effective in eradicating Hib in this model which was critical to studying the non antibiotic related activity of polymyxin B in overwhelming Hib infection.) A total of three doses of antibiotics were given 3 h apart and antibiotic treatment was initiated 3 h after intraperitoneal injection of HibE. Consecutive quantitative blood Ampicillin 100 g / m l + Polymyxin 8.7 X lo6 1 5,000 3.5 X lo6 20,000 B 0.1 uglrnl * Results are the means of two separate experiments. Broths were incubated for 2 h prior to the addition of antibiotics at which time the colony counts were 7.7 X 10' cfu/ml and endotoxin activity in filtered, sterile supernatants was 3000 ng/ml. cultures were obtained from tail veins at 8 and between 18 and 20 h after infection in a random sample of 6 ampicillin and 14 polymyxin B-treated animals. Mortality was monitored every 3 h for 27 h after infection was initiated. At 5 h after initiation of treatment no growth was noted from cultures plated at a dilution in ampicillin-treated animals, whereas in the polymyxin B group all blood cultures were positive containing from 2 x lo6 to 7 x 10' cfu/ml ( p = 0.0001). Eighteen to 20 h after infection, all 12 animals in the ampicillin group remained alive, whereas seven of 20 animals in the polymyxin B group had died ( p = 0.05). Survivors that had sequential blood cultures performed in the polymyxin B group (n = 9) continued to have positive blood cultures with bacterial concentrations ranging from 1 x 10' to 6.4 x 10' cfu/ml. In contrast, only two of six sequentially sampled animals in the ampicillin group had positive blood cultures (2 and 7 x 106 cfu/ml) ( p = 0.048).
These results confirmed that a 0.5 mg/kg dose of ampicillin administered three times every three hours was protective if initiated within 3 h of infection. In contrast, a low dose (0.0125 mg/kg) of polymyxin B was not effective in preventing bacteremia and one-third of these animals died.
Eflcacy ~fAmpicillin or subinhibitory polymyxin B on survival when treatment was delayed for 12 h after infection. Infant rats were infected ip with 4.7 x lo6 HibE (range 1.6 to 7 x lo6 cfu). All inoculations were performed at 2100 h. Twelve h after infection was initiated, surviving animals were weighed and randomly assigned to antimicrobial treatment groups. Care was taken to assign approximately equal numbers of infant rats in each litter to two or three treatment modalities to control for possible differences related to maternal protective factors, ie. milk or nursing behavior. Antimicrobial treatment consisted of one of the following five regimens: PBS (16 animals), ampicillin at 0.5 mg/kg/dose (low dose, 30 animals) or at 500 mg/kg/dose (high dose, 45 animals), polymyxin B at 0.0 125 mg/kg/dose (1 7 animals), or a combination of high dose ampicillin plus polymyxin B at 0.0125 mg/kg/dose (27 animals). Antibiotics were first administered 12 h after the ip injection of HibE and were given three times at three hour intervals. Antibiotics were diluted in PBS such that a volume of 0.1 m1/10 g body weight resulted in the appropriate dose in mg/kg. Intraperitoneal antibiotic injections were alternated between the right and left sides. Deaths were recorded hourly for 23 h and again at 36 h after infection.
The mortality of untreated animals 12 h after ip infection was 18.3%, confirming the advanced state of infection prior to institution of therapy. The observed death rates at 17, 20, and 36 h after infection in all five treatment groups are shown in Table 3 . Polymyxin B alone at 0.0125 mg/kg/dose every 3 h resulted in a significantly greater survival at 17 h ( p = 0.009) and 20 h ( p = 0.003) after infection compared to ampicillin at a 0.5 mg/ kg/dose given at the same time and interval. The addition of ampicillin at 500 mg/kg/dose to the same polymyxin B regimen did not result in further improvements of survival but the combination was superior to ampicillin (500 mg/kg) alone at 36 h after infection ( p = 0.026).
Colony counts and free endotoxin activity after antibiotic administration. The effects of the antibiotics on bacterial counts 240 WALTERSP 'IEL ET AL. (500) * p = 0.026, polymyxin/ampicillin 500 mg/kg combination against ampicillin 500 mg/kg alone. and the release of endotoxin were examined in animals receiving ampicillin 0.5 mg/kg and polymyxin B 0.0125 mg/kg. Quantitative bacterial and endotoxin concentrations were determined 2 h after the second dose of antibiotics in 11 surviving animals in each group. The results are shown in Table 4 . Ampicillintreated animals had a significantly decreased blood concentration of HibE compared to polymyxin B-treated animals (4 X lo6 versus 288 x lo6) ( p = 0.0007). The endotoxin activity did not differ significantly.
In order to avoid the bias present due to preexisting treatment dependent mortality rates in this above mentioned group, bacterial quantitation and endotoxin activities were determined within 30 to 45 min after the administration of a single dose of antibiotic in a separate experiment. Seventeen animals were given 0.1 m1/10 g body weight of PBS, six received 500 mg/kg ampicillin, and seven animals received 0.01 25 mg/kg polymyxin B. Animals receiving high dose ampicillin had a significntly lower ( p = 0.023) number of HibE in their blood than the PBS-treated animals, however, the endotoxin activity was significantly greater ( p = 0.006) in the ampicillin-treated animals than in the PBS treated group (Table 5 ). The polymyxin B-treated group did not differ from the control or ampicillin groups in any of the parameters. Thus, in vivo endotoxin activity was found to be significantly elevated at 30 min after a dose of ampicillin compared with saline-treated animals.
DISCUSSION
Our study demonstrates that ampicillin causes the release of endotoxin from HibE in vitro and in vivo, in the infant rat. A very low dose of polymyxin B, a potent neutralizing agent of endotoxin, promoted the survival of infected animals, when compared to treatment with ampicillin alone. Improved survival was also apparent when polymyxin B was given in conjunction with ampicillin. The addition of ampicillin in this later combination did not enhance survival over polymyxin B alone during the first 1 1 h of treatment, but by eradicating the infecting organism, no further mortality was observed after its discontinuation. (19, 20) and from E. coli in infected rabbits (3).
It is presently unknown if release of endotoxin either spontaneously, by the bactericidal action of serum, or by antibiotics is important in the pathogenesis or complications of human infections.
Antibodies directed against the core region of LPS in mice infected with Haemophilzls influenzae type b (6) and in humans with gram negative sepsis (2) have been successful in improving survival. Polymyxin B binds and neutralizes endotoxin and appears to be an effective alternative to antibody to core LPS in neutralizing endotoxin (10, 15) . Higher doses of polymyxin B than the ones used in our experiments were beneficial in experiments examining the mitigation of a range of biological actions due to purified endotoxin (8, 9, 1 1, 14, 16, 17, 24) .
In two other studies polymyxin B was given after an in vivo infection had been established (2 1, 22 ). These investigators used polymyxin B resistant organisms in order to distinguish between antimicrobial and endotoxin neutralizing activity. In one study, adult mice were infected with a N. meningitidis strain resistant to polymyxin B. Treatment (5 mg/kg) was initiated 3 h after infection and in 800 animals polymyxin B resulted in increased survival compared to untreated animals ( p < 0.05) (2 1). In the other study adult rabbits were infected with a polymyxin Bresistant Pasteurella multocida strain (22) . Polymyxin B treatment (5 mg/kg) was initiated 6 h after infection and 10 untreated animals were compared. The polymyxin B-treated animals exhibited lower serum endotoxin concentrations, higher platelet counts, and equal degrees of bacteremia, but overall mortality compared to penicillin-treated animals (10,000 U/kg) was not lower. A penicillin-polymyxin B combination seemed to be superior but the difference was not significant (p > 0.05).
We were able to separate the antimicrobial properties from the endotoxin neutralizing action of polymyxin B by comparing an effective ampicillin regimen to a dose of polymyxin B with negligible in vivo antimicrobial activity. In addition, we chose a state of disease at which time otherwise effective antimicrobial treatment was no longer efficacious in terms of survival. This experimental design simulates more closely the clinical conditions found in septic shock due to gram-negative organisms. The low dose of polymyxin B that was used in this experiment might have been advantageous by not triggering the release of histamine (a side effect of polymyxin B), to which animals that have received endotoxin are even more susceptible (23) .
As described by Conigan and Kiernat (22) polymyxin B may have neutralized endotoxin in circulation as the mechanism for prolonging survival. However, we could not convincingly demonstrate this with our low dose of polymyxin B at either 30 min after administration (the time for distribution might have been too short) or at 120 min after two doses, when a substantial number of ampicillin-treated animals had died and were unavailable for valid comparison. Alternatively, polymyxin B might have neutralized some of the toxic effects of endotoxin which are not associated with decreased endotoxin activity as measured by the limulus lysate assay, i.e. polymyxin B inhibiting C-kinase activity (24) . Increased survival seen with low doses of polymyxin B in a model of overwhelming infection with Hib may indicate the potential for such adjunct therapy for gram-negative infections in humans.
